Pfizer to Acquire Therachon In A $810 Million Deal
Posted by
www.biotecnika.org
Pfizer to Acquire Therachon In A $810 Million Deal Pfizer has agreed
to acquire Therachon Holdings in a deal of around $810 million. The
pact is meant to expand the buyer's rare disease portfolio with a
pipeline to be led by a clinical-phase candidate for the most common
form of short-limbed dwarfism. TA-46 completing Phase […]
The post Pfizer to Acquire Therachon In A $810 Million Deal appeared
first on BioTecNika .
https://www.biotecnika.org/2019/05/pfizer-to-acquire-therachon-in-a-810-million-deal/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment